GlassScriptPhysician profile
Theodore W Law
NPI 1447203583
$3,664.50
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $1,209 · 2021: $1,110 · 2022: $441.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $591.58 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $477.87 | 2019-2022 | |
| Lilly USA, LLC | $250.92 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.58 | 2019-2021 | |
| Abbvie INC. | $231.52 | 2019-2022 | |
| Amgen INC. | $224.42 | 2019-2022 | |
| Pfizer INC. | $186.82 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $177.95 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $171.98 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $160.06 | 2020-2021 | |
| Amarin Pharma, INC. | $137.74 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.87 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $119.32 | 2019-2022 | |
| Eisai INC. | $69.54 | 2021-2022 | |
| Abbott Laboratories | $62.25 | 2020-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $58.07 | 2021 | |
| Dexcom, INC. | $49.94 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $39.93 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $36.50 | 2022 | |
| Insulet Corporation | $33.54 | 2020 | |
| Vanda Pharmaceuticals INC. | $32.18 | 2020 | |
| Nestle Healthcare Nutrition INC. | $29.43 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.93 | 2021 | |
| Ironwood Pharmaceuticals, INC | $25.99 | 2020 | |
| Mannkind Corporation | $15.61 | 2020 | |
| Currax Pharmaceuticals LLC | $14.92 | 2021 | |
| Shire North American Group INC | $11.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.